DolPHIN2

Search

  • About DolPHIN 2
  • Research
    • Clinical trial
    • Qualitative research
    • Health Economics
    • Community Voices
  • Resources
  • News & Events
    • News
    • Events
    • Past events

Vertical transmission of HIV is preventable, and we have a duty to ensure the burden of HIV is not handed down across generations.

image source: pexels

The DolPHIN 2 programme investigates the safe and effective use of dolutegravir for women who present with untreated HIV in late pregnancy

The team at the Infectious Diseases Institute, Kampala

DolPHIN 2 is a multinational project led by the University of Liverpool which aims to reduce the rate of vertical transmission of HIV through research into a new HIV drug called dolutegravir.

0

How we work

About DolPHIN 2

Read about the challenges that the DolPHIN 2 project seeks to address and why.

The DolPHIN 2 Consortium

Learn more about our multinational research consortium, comprising partners in Europe and sub-Saharan Africa.

Community Voices

Collaboration with the community is at the heart of DolPHIN 2. Click here to learn more about our community engagement, and to hear from some of our study participants.
1

Resources

09 Aug 2024

Introducing a new HIV drug – three times faster

Unitaid show how they led the way in introducing dolutegravir three years faster than previous drugs.
Unitaid
Video
11 Aug 2022

Empower, Engage, Educate - Breastfeeding

Video
11 Aug 2022

Empower, Engage, Educate - Delivery

Video
11 Aug 2022

Empower, Engage, Educate - Male Involvement

Video
View all Resources
1

News

DolPHIN-2 presents on depressive symptoms at CROI 2024

15 Mar 2024

Prof Saye Khoo recognised in UK New Years Honours

09 Jan 2024
View all News and Events
1

Events

11th March 2024

British Science Week Parliamentary Reception

We showcased the DolPHIN-2 work at a parliamentary reception for British Science Week at the Houses of Parliament.
London, UK
2nd - 7th Dec 2019

ICASA Conference 2019

The DolPHIN 2 team will have a stand in the community village at the ICASA conference. Come along, say hello and learn more about the programme!

Kigali, Rwanda
7th- 8th May 2019

3rd Annual Consortium Meeting

Project teams from UCT, IDI, Radboudumc, LSTM and University of Liverpool converged in Cape Town for our third annual consortium meeting. Under discussion was the progress of the main DolPHIN2 trial so far as well as other potential sub-studies arising from our initial data.

Cape Town, South Africa
27th -29th March 2017

DolPHIN-2 Consortium meeting

After months of teleconferences, the  DolPHIN-2 project team finally came face to face at our first consortium meeting

Cape Town, South Africa

The D2 Consortium

The DolPHIN 2 consortium is a multinational partnership comprising five research organisations and our funder, Unitaid.

University of Liverpool

Liverpool School of Tropical Medicine

Infectious Diseases Institute

University of Cape Town

Radboud University Medical Centre

Unitaid

Contact us

dolphin [dot] admin [dot] team [at] liverpool [dot] ac [dot] uk

ClinicalTrials.gov Identifier: NCT03249181

Follow us

  • Twitter
A Remora website by Manta Ray Media